2020
DOI: 10.1126/sciadv.aba9338
|View full text |Cite
|
Sign up to set email alerts
|

A machine learning approach to define antimalarial drug action from heterogeneous cell-based screens

Abstract: Drug resistance threatens the effective prevention and treatment of an ever-increasing range of human infections. This highlights an urgent need for new and improved drugs with novel mechanisms of action to avoid cross-resistance. Current cell-based drug screens are, however, restricted to binary live/dead readouts with no provision for mechanism of action prediction. Machine learning methods are increasingly being used to improve information extraction from imaging data. These methods, however, work poorly wi… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
43
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 42 publications
(49 citation statements)
references
References 33 publications
0
43
0
Order By: Relevance
“…A strategy was developed to express mutant alleles of Pfmyoa from a second locus in the PfMyoA-cKO parasite line, to enable conditional mutation of any part of PfMyoA. We used the p230p locus (PlasmoDB ID PF3D7_0208900), identified as dispensable throughout the parasite life cycle [ 44 ] and developed for targeted CRISPR/Cas9 integration [ 45 ]. To facilitate gene replacement on top of the PfMyoA-cKO background, the p230p targeting plasmid (pDC2-p230p-hDHFR) was modified by the exchange of hdhfr for bsd , which encodes the blasticidin-S-deaminase resistance gene (since PfMyoA-cKO parasites already express hDHFR) to form the pDC2-p230p-BSD targeting plasmid ( Fig 1A ).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…A strategy was developed to express mutant alleles of Pfmyoa from a second locus in the PfMyoA-cKO parasite line, to enable conditional mutation of any part of PfMyoA. We used the p230p locus (PlasmoDB ID PF3D7_0208900), identified as dispensable throughout the parasite life cycle [ 44 ] and developed for targeted CRISPR/Cas9 integration [ 45 ]. To facilitate gene replacement on top of the PfMyoA-cKO background, the p230p targeting plasmid (pDC2-p230p-hDHFR) was modified by the exchange of hdhfr for bsd , which encodes the blasticidin-S-deaminase resistance gene (since PfMyoA-cKO parasites already express hDHFR) to form the pDC2-p230p-BSD targeting plasmid ( Fig 1A ).…”
Section: Resultsmentioning
confidence: 99%
“…For modification of the p230p locus in the PfMyoA-cKO background, targeting and repair constructs were modified from [ 45 ]. The targeting construct, pDC2-p230p-hDHFR, (originally adapted from [ 66 ]) carries 3xHA-tagged Cas9 and the p230p -targeting guide RNA.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The abilities of machine learning methods to improve information extraction from imaging data are finding new applications in mechanism of action studies. Because these methods do not work well with heterogeneous cellular phenotypes and require human training, Ashdown and coworkers reported a combined human- and machine-labelled approach for data from mixed human malaria parasite cultures ( Ashdown et al, 2020 ). Trained on high-throughput and high-resolution screening data, their approach tolerates natural parasite morphological heterogeneity and correctly orders parasite developmental stages.…”
Section: Perspectivementioning
confidence: 99%